-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Haizheng Pharmaceutical (600267.SH) issued an announcement. Recently, Haizheng Pharmaceutical (Hangzhou) Co., Ltd. (“Haizheng Hangzhou Company”), a wholly-owned subsidiary of the company, received a notice from the US Food and Drug Administration (“US FDA”). Haizheng Hangzhou's New Drug Application (ANDA, or US Generic Drug Application) declared to the US FDA has been approved, which means Haizheng Hangzhou can sell this product in the US market.

Zhitongcaijing·07/24/2026 08:57:04
Listen to the news
Zhitong Finance App News, Haizheng Pharmaceutical (600267.SH) issued an announcement. Recently, Haizheng Pharmaceutical (Hangzhou) Co., Ltd. (“Haizheng Hangzhou Company”), a wholly-owned subsidiary of the company, received a notice from the US Food and Drug Administration (“US FDA”). Haizheng Hangzhou's New Drug Application (ANDA, or US Generic Drug Application) declared to the US FDA has been approved, which means Haizheng Hangzhou can sell this product in the US market.